JAK2 and ovarian cancer: There was a good correlation between SENP1 and phosphorylated JAK2 levels in these tested sensitive and resistant patient tumor samples (Fig. 6E), indicating SENP1 upregulation is correlated with JAK2-mediated platinum-resistance in ovarian cancer.